choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Onglyza

Onglyza Newsletter
  • Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics 22 Apr 2024 21:47 GMT

    In its upcoming report, Astrazeneca AZN is predicted by … the average estimates of some Astrazeneca metrics that Wall Street … that 'Product Sales- CVRM- Onglyza' will reach $49.01 … . Over the past month, Astrazeneca shares have recorded returns of …

  • 2023 First Generic Drug Approvals 08 Mar 2024 22:36 GMT

    … Bulk Package B. Braun Medical, Inc. Calcium Gluconate in … 5 mg Sun Pharmaceutical Industries Limited Onglyza (Saxagliptin) Tablets 7 … , once-daily, maintenance treatment of bronchospasm associated with … are refractory to other drugs 18 213267 Thalidomide …

  • AstraZeneca gets CDSCO Panel Nod To update Prescribing Information of Antidiabetic FDC 07 Mar 2024 18:16 GMT

    … .” This came after the drug major AstraZeneca presented the proposal for an … .11.2022. Saxagliptin (Onglyza) is an oral antihyperglycemic drug in the dipeptidyl … is in a class of medications called sodium-glucose co-transporter …

  • Royalty Pharma Reports First Quarter 2024 Results 09 May 2024 11:00 GMT

    … acquisition of Karuna. Bristol Myers acquired Karuna for … New Drug Application for KarXT for the treatment of … -cap biotechnology companies to leading global pharmaceutical companies. … Emgality, Entyvio, Farxiga/Onglyza, IDHIFA, Letairis, Lexiscan, Mircera …

  • Appeals court: Diabetes drug causation claims don’t stand up 15 Feb 2024 00:09 GMT

    … that Onglyza (saxagliptin) and Kombiglyze (saxagliptin/metformin hydrochloride), developed by Astrazeneca … plc and Bristol Myers Squibb Co., caused …

  • Appeals court sides with AstraZeneca, BMS, McKesson in saxagliptin heart failure case 14 Feb 2024 20:04 GMT

    … a de­ci­sion in fa­vor of As­traZeneca, Bris­tol My­ers Squibb and McKesson in … the dis­con­tin­ued type 2 di­a­betes treat­ments Ong­lyza and Kom­biglyze. It’s a … ex­er­cise. But in 2016, an FDA safe­ty re­view found that saxagliptin …

  • Case Dismissed: Appeals Court Slams Expert Witness in Diabetes Drug Lawsuits 15 Feb 2024 07:56 GMT

    … dozens of others against Bristol-Myers Squibb Co., AstraZeneca Pharmaceuticals and two more … of Medicine. Goyal said that saxagliptin, sold under the brand name Onglyza … the FDA, which triggered many class-action lawsuits against the drug manufacturers …

  • AstraZeneca PLC (LON:AZN) Announces Dividend of GBX 156 09 Feb 2024 13:37 GMT

    … on AZN About AstraZeneca (Get Free Report) AstraZeneca PLC, a biopharmaceutical … development, manufacture, andcommercialization of prescription medicines. The company's marketed … Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and …

  • Janney Montgomery Scott LLC Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN) 09 Feb 2024 13:31 GMT

    … Our Latest Stock Analysis on AstraZeneca AstraZeneca Stock Performance Shares of … , manufacture, andcommercialization of prescription medicines. The company's marketed … Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and …

  • AstraZeneca PLC (NASDAQ:AZN) Receives $80.00 Consensus Target Price from Brokerages 09 Feb 2024 08:40 GMT

    … fiscal year. About AstraZeneca (Get Free Report AstraZeneca PLC, a biopharmaceutical … , manufacture, andcommercialization of prescription medicines. The company's marketed … Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and …

Satisfied with the content?

Continue to create your account.